Houseviews: 4 stocks that you can buy in today’s trade

Houseviews: 4 stocks that you can buy in today’s trade
  • Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney IThe Winning Leap SME Special
Moneycontrol
Houseviews: 4 stocks that you can buy in today’s trade
  • 
	Sun Pharmaceutical Industries

	Brokerage: Bank of America Merrill Lynch

	Rating: Buy

	Target: Rs 855

	Rationale: They expect consensus upgrades to drive re-rating, driven by sustenance of Taro product increase aiding margins, synergies from URL and DUSA acquisitions and resumption of Caraco sales.

    Sun Pharmaceutical Industries Brokerage: Bank of America Merrill Lynch Rating: Buy Target: Rs 855 Rationale: They expect consensus upgrades to drive re-rating, driven by sustenance of Taro product increase aiding margins, synergies from URL and DUSA acquisitions and resumption of Caraco sales.

  • 
	Bharat Forge

	Brokerage: I-SEC

	Rating: Buy

	Target: Rs 237

	Rationale: Valuations are factoring in most of the concerns and present an opportunity to gain from a revival in the automobile sector in FY15.

    Bharat Forge Brokerage: I-SEC Rating: Buy Target: Rs 237 Rationale: Valuations are factoring in most of the concerns and present an opportunity to gain from a revival in the automobile sector in FY15.

  • 
	Tata Motors

	Brokerage: CLSA

	Rating: Buy

	Target: NA

	Rationale: JLR's product transformation story is likely to gain pace and the rising share of SUVs in luxury auto sales. Improving china penetration will drive market share gains for JLR.

    Tata Motors Brokerage: CLSA Rating: Buy Target: NA Rationale: JLR's product transformation story is likely to gain pace and the rising share of SUVs in luxury auto sales. Improving china penetration will drive market share gains for JLR.

  • 
	Mahindra and Mahindra

	Brokerage: Religare

	Rating: Buy

	Target: Rs 1100

	Rationale: Strong volume outperformance and pricing action in the months ahead should help improve the margin trajectory.

    Mahindra and Mahindra Brokerage: Religare Rating: Buy Target: Rs 1100 Rationale: Strong volume outperformance and pricing action in the months ahead should help improve the margin trajectory.

  • 
	Sun Pharmaceutical Industries

	Brokerage: Bank of America Merrill Lynch

	Rating: Buy

	Target: Rs 855

	Rationale: They expect consensus upgrades to drive re-rating, driven by sustenance of Taro product increase aiding margins, synergies from URL and DUSA acquisitions and resumption of Caraco sales.
  • 
	Bharat Forge

	Brokerage: I-SEC

	Rating: Buy

	Target: Rs 237

	Rationale: Valuations are factoring in most of the concerns and present an opportunity to gain from a revival in the automobile sector in FY15.
  • 
	Tata Motors

	Brokerage: CLSA

	Rating: Buy

	Target: NA

	Rationale: JLR's product transformation story is likely to gain pace and the rising share of SUVs in luxury auto sales. Improving china penetration will drive market share gains for JLR.
  • 
	Mahindra and Mahindra

	Brokerage: Religare

	Rating: Buy

	Target: Rs 1100

	Rationale: Strong volume outperformance and pricing action in the months ahead should help improve the margin trajectory.

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login